Home › Funds › LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA › IDXX

LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA position in IDXX

IDEXX LABS INC · Health Care

LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA reported holding 114,834 shares of IDXX (IDEXX LABS INC) in its Q3 2026 13F filing — a position valued at US$60.0M, representing 0.55% of its reported portfolio and ranking #42 among its reported holdings. LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA has disclosed IDXX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)114.83K sh
Reported value held$59.97M
Portfolio Weight0.55%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA's IDXX position evolved

LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA first disclosed a stake in IDXX in Q3 2023 at 150,364 shares (US$63.1M). The position peaked in Q4 2025 at 124,045 shares, worth US$86.2M. Across 13 filings, LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA increased the stake 0 time(s), trimmed it 11 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 114,834 shares valued at US$60.0M — a reduction of -2,361 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 150.36K $63.07M New
Q4 2023 141.80K $73.04M Reduce
Q1 2024 140.28K $67.27M Reduce
Q2 2024 139.21K $69.54M Reduce
Q3 2024 134.83K $60.98M Reduce
Q4 2024 134.46K $57.48M Hold
Q1 2025 133.78K $57.07M Reduce
Q2 2025 131.68K $70.63M Reduce
Q3 2025 127.11K $81.17M Reduce
Q4 2025 124.05K $86.18M Reduce
Q1 2026 122.30K $68.86M Reduce
Q2 2026 117.19K $61.70M Reduce
Q3 2026 114.83K $59.97M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IDXX and 13F data

IDXX (IDEXX LABS INC) is a Health Care company. 28 other funds we track also report a position in IDXX — the largest reported positions include Baron Funds (US$1.04B), BAMCO INC /NY/ (US$1.04B), Fundsmith LLP (US$536.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IDXX

All IDXX fund holders →

FAQ

How long has LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA held IDXX?

LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA has disclosed IDXX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA's current position in IDXX?

As of Q3 2026, LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA holds 114.83K shares of IDXX (IDEXX LABS INC), valued at $59.97M, representing 0.55% of its reported portfolio and ranking #42.

Has LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA been buying or selling IDXX?

In the latest 13F filing (Q3 2026), LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA reduced its position in IDXX. The position peaked in Q4 2025 at 124.05K shares.

Which other funds hold IDXX?

Other major institutional holders of IDXX include Baron Funds, BAMCO INC /NY/, Fundsmith LLP, among 28 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.